June 25, 2022

The Japan Herald

About Japan, Global Green Energy and Space Market

Orally Dissolving Film Drug Scanner Trends and Forecast Report 2022 | By Players, Types, Applications and Regions

9 min read

The QY Research released a latest market research report on the global and United States Orally Dissolving Film Drug market, which is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Orally Dissolving Film Drug Scanner will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

 

For United States market, this report focuses on the Orally Dissolving Film Drug Scanner size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

 

For More Information About This Report, Please Enter:

https://us.qyresearch.com/reports/355291/orally-dissolving-film-drug

Segment by Type

Orodispersible Film

Oromucosal Film

 

Segment by Application

Hospitals

Drugstores

Others

 

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

 

By Company

GSK

LTS

J&J

Indivior

Pfizer

Sanofi

Church & Dwight

tesa Labtec

Tapemark

Prestige

Sun Pharma

MonoSol

BioDelivery

Arx

ZIM

NAL Pharma

AdhexPharma

Aavishkar

IntelGenx Corp

APR

 

 

The Goal of the Report

To study and analyze the global Orally Dissolving Film Drug Scanner    consumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.

To understand the structure of Orally Dissolving Film Drug Scanner    by identifying its various sub segments.

Focuses on the key global Orally Dissolving Film Drug Scanner    manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Orally Dissolving Film Drug Scanner    with respect to individual growth trends, prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).

To project the consumption of Orally Dissolving Film Drug Scanner    sub markets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

 

Target Audience

> Orally Dissolving Film Drug Scanner    companies

> Research organizations

> Government Organizations

> Research/Consultancy firms

 

Table of Contents

1 Study Coverage
1.1 Orally Dissolving Film Drug Product Introduction
1.2 Global Orally Dissolving Film Drug Outlook 2017 VS 2022 VS 2028
1.2.1 Global Orally Dissolving Film Drug Sales in US$ Million for the Year 2017-2028
1.2.2 Global Orally Dissolving Film Drug Sales in Volume for the Year 2017-2028
1.3 United States Orally Dissolving Film Drug Outlook 2017 VS 2022 VS 2028
1.3.1 United States Orally Dissolving Film Drug Sales in US$ Million for the Year 2017-2028
1.3.2 United States Orally Dissolving Film Drug Sales in Volume for the Year 2017-2028
1.4 Orally Dissolving Film Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Orally Dissolving Film Drug in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Orally Dissolving Film Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Orally Dissolving Film Drug Market Dynamics
1.5.1 Orally Dissolving Film Drug Industry Trends
1.5.2 Orally Dissolving Film Drug Market Drivers
1.5.3 Orally Dissolving Film Drug Market Challenges
1.5.4 Orally Dissolving Film Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered

2 Market by Type
2.1 Orally Dissolving Film Drug Market Segment by Type
2.1.1 Orodispersible Film
2.1.2 Oromucosal Film
2.2 Global Orally Dissolving Film Drug Market Size by Type
2.2.1 Global Orally Dissolving Film Drug Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Orally Dissolving Film Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Orally Dissolving Film Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Orally Dissolving Film Drug Market Size by Type
2.3.1 United States Orally Dissolving Film Drug Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Orally Dissolving Film Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Orally Dissolving Film Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)

3 Market by Application
3.1 Orally Dissolving Film Drug Market Segment by Application
3.1.1 Hospitals
3.1.2 Drugstores
3.1.3 Others
3.2 Global Orally Dissolving Film Drug Market Size by Application
3.2.1 Global Orally Dissolving Film Drug Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Orally Dissolving Film Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Orally Dissolving Film Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Orally Dissolving Film Drug Market Size by Application
3.3.1 United States Orally Dissolving Film Drug Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Orally Dissolving Film Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Orally Dissolving Film Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)

4 Global Orally Dissolving Film Drug Competitor Landscape by Company
4.1 Global Orally Dissolving Film Drug Market Size by Company
4.1.1 Top Global Orally Dissolving Film Drug Manufacturers Ranked by Revenue (2021)
4.1.2 Global Orally Dissolving Film Drug Revenue by Manufacturer (2017-2022)
4.1.3 Global Orally Dissolving Film Drug Sales by Manufacturer (2017-2022)
4.1.4 Global Orally Dissolving Film Drug Price by Manufacturer (2017-2022)
4.2 Global Orally Dissolving Film Drug Concentration Ratio (CR)
4.2.1 Orally Dissolving Film Drug Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Orally Dissolving Film Drug in 2021
4.2.3 Global Orally Dissolving Film Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Orally Dissolving Film Drug Manufacturing Base Distribution, Product Type
4.3.1 Global Orally Dissolving Film Drug Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Orally Dissolving Film Drug Product Type
4.3.3 Date of International Manufacturers Enter into Orally Dissolving Film Drug Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Orally Dissolving Film Drug Market Size by Company
4.5.1 Top Orally Dissolving Film Drug Players in United States, Ranked by Revenue (2021)
4.5.2 United States Orally Dissolving Film Drug Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Orally Dissolving Film Drug Sales by Players (2020, 2021 & 2022)

5 Global Orally Dissolving Film Drug Market Size by Region
5.1 Global Orally Dissolving Film Drug Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Orally Dissolving Film Drug Market Size in Volume by Region (2017-2028)
5.2.1 Global Orally Dissolving Film Drug Sales in Volume by Region: 2017-2022
5.2.2 Global Orally Dissolving Film Drug Sales in Volume Forecast by Region (2023-2028)
5.3 Global Orally Dissolving Film Drug Market Size in Value by Region (2017-2028)
5.3.1 Global Orally Dissolving Film Drug Sales in Value by Region: 2017-2022
5.3.2 Global Orally Dissolving Film Drug Sales in Value by Region: 2023-2028

6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Orally Dissolving Film Drug Market Size YoY Growth 2017-2028
6.1.2 North America Orally Dissolving Film Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Orally Dissolving Film Drug Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Orally Dissolving Film Drug Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Orally Dissolving Film Drug Market Size YoY Growth 2017-2028
6.3.2 Europe Orally Dissolving Film Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Orally Dissolving Film Drug Market Size YoY Growth 2017-2028
6.4.2 Latin America Orally Dissolving Film Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.4.6 Colombia
6.5 Middle East and Africa
6.5.1 Middle East and Africa Orally Dissolving Film Drug Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Orally Dissolving Film Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE

7 Company Profiles
7.1 GSK
7.1.1 GSK Corporation Information
7.1.2 GSK Description and Business Overview
7.1.3 GSK Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.1.4 GSK Orally Dissolving Film Drug Products Offered
7.1.5 GSK Recent Development
7.2 LTS
7.2.1 LTS Corporation Information
7.2.2 LTS Description and Business Overview
7.2.3 LTS Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.2.4 LTS Orally Dissolving Film Drug Products Offered
7.2.5 LTS Recent Development
7.3 J&J
7.3.1 J&J Corporation Information
7.3.2 J&J Description and Business Overview
7.3.3 J&J Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.3.4 J&J Orally Dissolving Film Drug Products Offered
7.3.5 J&J Recent Development
7.4 Indivior
7.4.1 Indivior Corporation Information
7.4.2 Indivior Description and Business Overview
7.4.3 Indivior Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Indivior Orally Dissolving Film Drug Products Offered
7.4.5 Indivior Recent Development
7.5 Pfizer
7.5.1 Pfizer Corporation Information
7.5.2 Pfizer Description and Business Overview
7.5.3 Pfizer Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Pfizer Orally Dissolving Film Drug Products Offered
7.5.5 Pfizer Recent Development
7.6 Sanofi
7.6.1 Sanofi Corporation Information
7.6.2 Sanofi Description and Business Overview
7.6.3 Sanofi Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Sanofi Orally Dissolving Film Drug Products Offered
7.6.5 Sanofi Recent Development
7.7 Church & Dwight
7.7.1 Church & Dwight Corporation Information
7.7.2 Church & Dwight Description and Business Overview
7.7.3 Church & Dwight Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Church & Dwight Orally Dissolving Film Drug Products Offered
7.7.5 Church & Dwight Recent Development
7.8 tesa Labtec
7.8.1 tesa Labtec Corporation Information
7.8.2 tesa Labtec Description and Business Overview
7.8.3 tesa Labtec Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.8.4 tesa Labtec Orally Dissolving Film Drug Products Offered
7.8.5 tesa Labtec Recent Development
7.9 Tapemark
7.9.1 Tapemark Corporation Information
7.9.2 Tapemark Description and Business Overview
7.9.3 Tapemark Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Tapemark Orally Dissolving Film Drug Products Offered
7.9.5 Tapemark Recent Development
7.10 Prestige
7.10.1 Prestige Corporation Information
7.10.2 Prestige Description and Business Overview
7.10.3 Prestige Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Prestige Orally Dissolving Film Drug Products Offered
7.10.5 Prestige Recent Development
7.11 Sun Pharma
7.11.1 Sun Pharma Corporation Information
7.11.2 Sun Pharma Description and Business Overview
7.11.3 Sun Pharma Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Sun Pharma Orally Dissolving Film Drug Products Offered
7.11.5 Sun Pharma Recent Development
7.12 MonoSol
7.12.1 MonoSol Corporation Information
7.12.2 MonoSol Description and Business Overview
7.12.3 MonoSol Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.12.4 MonoSol Products Offered
7.12.5 MonoSol Recent Development
7.13 BioDelivery
7.13.1 BioDelivery Corporation Information
7.13.2 BioDelivery Description and Business Overview
7.13.3 BioDelivery Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.13.4 BioDelivery Products Offered
7.13.5 BioDelivery Recent Development
7.14 Arx
7.14.1 Arx Corporation Information
7.14.2 Arx Description and Business Overview
7.14.3 Arx Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Arx Products Offered
7.14.5 Arx Recent Development
7.15 ZIM
7.15.1 ZIM Corporation Information
7.15.2 ZIM Description and Business Overview
7.15.3 ZIM Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.15.4 ZIM Products Offered
7.15.5 ZIM Recent Development
7.16 NAL Pharma
7.16.1 NAL Pharma Corporation Information
7.16.2 NAL Pharma Description and Business Overview
7.16.3 NAL Pharma Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.16.4 NAL Pharma Products Offered
7.16.5 NAL Pharma Recent Development
7.17 AdhexPharma
7.17.1 AdhexPharma Corporation Information
7.17.2 AdhexPharma Description and Business Overview
7.17.3 AdhexPharma Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.17.4 AdhexPharma Products Offered
7.17.5 AdhexPharma Recent Development
7.18 Aavishkar
7.18.1 Aavishkar Corporation Information
7.18.2 Aavishkar Description and Business Overview
7.18.3 Aavishkar Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Aavishkar Products Offered
7.18.5 Aavishkar Recent Development
7.19 IntelGenx Corp
7.19.1 IntelGenx Corp Corporation Information
7.19.2 IntelGenx Corp Description and Business Overview
7.19.3 IntelGenx Corp Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.19.4 IntelGenx Corp Products Offered
7.19.5 IntelGenx Corp Recent Development
7.20 APR
7.20.1 APR Corporation Information
7.20.2 APR Description and Business Overview
7.20.3 APR Orally Dissolving Film Drug Sales, Revenue and Gross Margin (2017-2022)
7.20.4 APR Products Offered
7.20.5 APR Recent Development

8 Industry Chain and Sales Channels Analysis
8.1 Orally Dissolving Film Drug Industry Chain Analysis
8.2 Orally Dissolving Film Drug Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Orally Dissolving Film Drug Distributors
8.3 Orally Dissolving Film Drug Production Mode & Process
8.4 Orally Dissolving Film Drug Sales and Marketing
8.4.1 Orally Dissolving Film Drug Sales Channels
8.4.2 Orally Dissolving Film Drug Distributors
8.5 Orally Dissolving Film Drug Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Access full Report Description, Table of Figure, Chart, FREE sample, etc. please click 

https://us.qyresearch.com/reports/355291/orally-dissolving-film-drug

Any doubts and questions will be welcome.

 

Customization of the Report:

This report can be customized to meet the client’s requirements. Please contact with us ([email protected]), who will ensure that you get a report that suits your needs.

 

About Us:

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company With over 15 years’ experience and professional research team in various cities over the world,QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let’s work closely with you and build a bold and better future.

 

Contact Us

QY Research

E-mail: [email protected]

Tel: +1-626-842-1666(US)   +852-5808-0956 (HK)

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

Website: https://us.qyresearch.com

 

Leave a Reply

Your email address will not be published. Required fields are marked *